1395PLung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors. (23rd October 2018) - Imyanitov, E N; Mitiushkina, N V; Tiurin, V I; Iyevleva, A G; Holmatov, M; Filippova, E; Moiseyenko, F; Levchenko, N; Odintsova, S; Lozhkina, A; Togo, A V; Karaseva, N; et al.